• Skip to main content
  • Skip to primary sidebar

PHYTOEXTRACTUM

The original banner for Phytoextractum
  • Home
  • Log In
  • Buy Kratom
    • Kratom Powder
    • Kratom Extract
    • Kratom Capsules
    • Kratom Shots
  • FAQ
  • Free Shipping!
  • About Us
  • Discount Codes
  • Free Stuff
  • Resources

advocacy

That’s Not Kratom. Here’s What Phytoextractum Sells Instead.

October 8, 2026 by Phyto

Last updated October 8, 2026. Update log at the end of this post.

If you follow kratom news, the last two weeks have been loud. Two University of Mississippi students died on September 21, and the first reports said packaged kratom was found at both scenes. The story has moved a long way from that first sentence since then. The first sentence is still the one most people heard.

We have been selling kratom since 2005, which means we have watched this cycle more than once. So here is the short, sourced version: what was reported, what the court record now says, and how our products are made and tested, so you can judge them on something better than a headline.

In brief

  • Court records identify the product as Smax Pseudo-DHM tablets. The package lists pseudoindoxyl, MGM-15 (DHM), and 7-hydroxymitragynine.
  • Two of those are lab-made derivatives of 7-OH that federal regulators say do not occur in the kratom plant. They have been Schedule I controlled substances since August 26, 2026.
  • Kratom leaf and its main alkaloid, mitragynine, are not federally controlled. The DEA’s order says so in plain terms.
  • A toxicology report cited by prosecutors lists mitragynine, MGM-15, and mitragynine pseudoindoxyl as present. No cause of death has been announced.
  • Phytoextractum products are made from Mitragyna speciosa leaf, in a cGMP facility, and tested by outside labs. Nothing synthetic is added.

What’s being reported

  • September 22–24Local police say “packaged kratom” purchased at retail stores was found in both investigations. National outlets run with it. Some headlines reach for the “gas station heroin” tag.
  • September 28A Lafayette County affidavit names the product: Smax Pseudo-DHM tablets, with pseudoindoxyl, MGM-15 (DHM), and 7-hydroxymitragynine printed on the package. Two employees of an Oxford vape shop are arrested.
  • September 29–30The American Kratom Association asks news organizations to identify the product by name instead of calling it kratom, and holds a press conference in Oxford.
  • October 2–3Federal prosecutors charge the shop’s manager and his son with possession with intent to distribute a controlled substance. Their filing says a toxicology report found mitragynine, MGM-15, and mitragynine pseudoindoxyl in both students, the same compounds as the tablets.
  • October 8Autopsy and toxicology reports have not been released. Investigators have not said what caused either death.

What the record actually says

The product on the label was not leaf. Mitragynine pseudoindoxyl and MGM-15 are chemically modified forms of 7-OH. The DEA placed both, along with a third compound called MGM-16, in Schedule I on August 26, 2026, after HHS confirmed they do not occur naturally in the plant. That order runs through August 2028. In other words, the tablets in this case were being sold roughly a month after their listed ingredients became federally illegal.

The leaf is not what got scheduled. The same DEA notice states that it does not apply to botanical kratom products containing naturally occurring 7-OH. Mitragynine and Mitragyna speciosa leaf remain federally uncontrolled. A separate DEA notice covering concentrated 7-OH above a set threshold was filed in July and has not been finalized as of this writing.

“Present in toxicology” is not “cause of death.” A toxicology screen lists what was found. The cause of death is a medical examiner’s ruling, and that ruling has not been made public. We are not going to guess at it, and we would ask readers not to either.

Why the word “kratom” stuck. These products are sold on the kratom shelf, often with “kratom” on the package. Police described what they found the way the package described it. Reporters quoted the police. By the time the ingredient list surfaced in court paperwork a week later, the first version of the story had already done its traveling.

Leaf productWhat the affidavit describes
Made fromDried Mitragyna speciosa leaf, or an extract concentrated from that leafLaboratory-made derivatives of 7-OH pressed into tablets
Federal statusNot controlledSchedule I since August 26, 2026
How you’d knowIngredient panel names the plant; a lab report is availableLabel says “pseudo,” “DHM,” “MGM-15,” or lists 7-OH in milligrams

A tablet is a format. An ingredient list is a fact.

— Phytoextractum

Why Phytoextractum products are different

Not different as a slogan. Different in ways you can check.

  • Leaf, start to finish. Every kratom product in our catalog, including powders, capsules, softgels, tablets, and our Platinum and UEI extracts, is made from Mitragyna speciosa leaf. Our extracts concentrate the alkaloids already in the leaf. We do not add synthetic or isolated 7-OH, mitragynine pseudoindoxyl, MGM-15, or any other lab-made derivative to anything we sell.
  • Yes, we sell kratom tablets. They are compressed leaf. A tablet is just a shape. What matters is the ingredient panel, and ours names the plant.
  • GMP, with outside labs. Phytoextractum is an American Kratom Association GMP Qualified Kratom Vendor. Products are tested for identity, heavy metals (arsenic, cadmium, lead, mercury), and microbial safety, using two or more independent labs. Details are on our quality assurance page, and a certificate of analysis is available on request for any product.
  • Twenty years of doing this the same way. We were one of the first kratom vendors in the United States. The receiving, testing, and quarantine procedures we use today were built over two decades, not two weeks.
  • We follow the map. Kratom’s legal status varies by state and city, and we do not ship where it is prohibited. Our shipping restrictions page is kept current.

Three questions to ask about any kratom product

  1. What does the ingredient panel say? A leaf product names the plant. Walk away from anything listing 7-OH in milligrams, or using “pseudo,” “DHM,” “MGM-15,” or “isolate.”
  2. Can you see a lab result? Identity and contaminant testing at minimum. If the seller can’t produce one, that is your answer.
  3. Who made it? A named company, a real facility, a GMP program, and a track record. A gas-station blister pack with a cartoon on it does not have any of those.

Judge the product, not the headline.

Read how we test, or request a certificate of analysis for anything in our catalog.

How We Test Request a COA

Quick answers

Was the product in the Ole Miss case kratom?

Not by its own label. The affidavit lists pseudoindoxyl, MGM-15 (DHM), and 7-hydroxymitragynine as the ingredients of Smax Pseudo-DHM tablets. The first two are synthetic derivatives of 7-OH that do not occur in the kratom plant, and both have been federal Schedule I controlled substances since August 26, 2026.

Has a cause of death been determined?

Not publicly. A federal court filing describes a toxicology report listing mitragynine, MGM-15, and mitragynine pseudoindoxyl as present in both students. Autopsy and toxicology reports have not been released, and investigators have not said what caused either death.

Do Phytoextractum products contain 7-OH?

Only what occurs naturally in kratom leaf, at trace levels. We do not add synthetic or isolated 7-OH, mitragynine pseudoindoxyl, MGM-15, or any lab-made derivative to any product. Our extracts concentrate the leaf’s own alkaloids. A certificate of analysis is available on request.

Update log

October 8, 2026 — Published. Cause of death not announced; 7-OH threshold scheduling order not yet finalized.

Sources

  1. American Kratom Association, “Calls on News Outlets to Correct the Record,” September 29, 2026.
  2. U.S. Drug Enforcement Administration, “DEA to Temporarily Schedule 7-OH and Related Substances,” July 1, 2026.
  3. Federal Register, temporary placement of mitragynine pseudoindoxyl, MGM-15, and MGM-16 in Schedule I, effective August 26, 2026.
  4. Associated Press / U.S. News, “Prosecutors Probing Deaths of 2 Ole Miss Students Charge Shop Clerk, Son,” October 2, 2026.
  5. WMC Action News 5 / Gray News, “Shop clerk, son charged with selling illegal kratom amid probe into Ole Miss student deaths,” October 3, 2026.
  6. CNN via ABC7, “How are kratom and drugs like 7-OH different? Explaining products found near dead Ole Miss students,” October 4, 2026.
  7. FOX13 Memphis, “Investigators find same tablets in rooms of two Ole Miss students who died,” September 29, 2026.

This article is for informational purposes only and reflects publicly available records as of the dates shown. It is not legal or medical advice. These statements have not been evaluated by the Food and Drug Administration. Phytoextractum products are not intended to diagnose, treat, cure, or prevent any disease.

Filed Under: Kratom Tagged With: 7OH, advocacy, legal, mitragyna speciosa, news

Kratom Laws in 2026: Your State-by-State Guide

March 4, 2026 by Phyto

If you’ve been following our blog, you know that the kratom legal landscape has been shifting at an unprecedented pace. Between new bans, breakthrough protections, and a wave of pending bills, 2025 and early 2026 have been some of the most consequential months in kratom’s legislative history.

We built this guide as a single resource you can bookmark and come back to. Below you’ll find an interactive map, a searchable state table, a timeline of the biggest recent developments, and more. Whether you’re a long-time advocate or just getting up to speed, this is everything you need to know about kratom’s legal standing right now.

⚠️ Important Disclaimer This guide is for informational purposes only and does not constitute legal advice. Laws change frequently — always verify your local and state regulations before making any purchasing decisions. If you have specific legal questions, please consult a qualified attorney in your state.

Interactive Legal Status Map

Click or hover over any state to see its current kratom legal status and recent developments. Use the filter buttons below the map to highlight specific categories.

Legal & Regulated (KCPA)
Legal (No Specific Law)
Restricted / Partial
Banned
Pending Major Legislation

What Changed in 2025–2026: A Timeline

Here’s a quick look at the most significant legislative developments over the past year. Green events represent wins for kratom access; red events represent new bans or restrictions; orange marks pending or mixed developments.

May 2025
South Carolina Signs KCPA Into Law

South Carolina’s KCPA went into effect, requiring retailers to keep kratom products in locked display cases and setting limits on synthetic alkaloid content — a model for responsible regulation.

June 2025
Connecticut Governor Signs HB6855

In a disappointing development, Connecticut’s governor signed a bill that designated kratom and its derivatives — including 7-OH — as Schedule I substances. Enforcement began in February 2026.

July 2025
Rhode Island Reverses Its Ban 🎉

In a historic first, Rhode Island passed legislation to reverse its kratom ban and transition to a regulated framework. The new rules take effect April 1, 2026 — making it the first state to reverse course on a kratom prohibition.

July 2025
HHS Recommends 7-OH Scheduling

The HHS emergency scheduling recommendation placed synthetic 7-hydroxymitragynine firmly in Schedule I at the federal level. This targets synthetic derivatives — not natural kratom — but it has accelerated state-level action on 7-OH products.

August 2025
Louisiana Ban Takes Effect

Louisiana’s SB 154 went into effect, making it the 6th state to fully prohibit kratom. The law reclassified key kratom alkaloids as Schedule I substances with penalties up to 5 years imprisonment. Phytoextractum can no longer ship to Louisiana addresses.

December 2025
Ohio Issues Emergency Kratom Rule

Ohio’s Board of Pharmacy issued an emergency rule banning most kratom products except those composed solely of pure mitragynine. The 180-day window for permanent rulemaking is underway.

March 2026
Spokane, WA Enacts City-Level Ban

The city of Spokane, Washington enacted a local ban on kratom sales — a reminder that even in legal states, local jurisdictions can impose their own restrictions.

April 2026
Tennessee Signs Full Kratom Ban

Governor Lee signed HB1649 (“Matthew Davenport’s Law”), making Tennessee the 8th state to fully prohibit kratom. The law bans all kratom products — natural leaf and 7-OH alike — effective July 1, 2026. Possession becomes a Class A misdemeanor and sale a Class C felony. Phytoextractum will no longer be able to ship to Tennessee addresses once the ban takes effect.

Full State-by-State Reference Table

Search for your state below. This table includes every state’s current status, age requirements (where applicable), and notes on recent or pending changes.

AlabamaBanned
Banned since 2016. Alkaloids classified Schedule I.
AlaskaLegal
No statewide law. Proposed Anchorage ban pending.
ArizonaRegulated
KCPA in effect.
Age: 18+
ArkansasBanned
Full statewide prohibition.
CaliforniaLegal
No specific kratom regulation.
ColoradoRegulated
KCPA. Denver has local ban. Synthetic 7-OH banned.
Age: 18+
ConnecticutBanned
NEW: Schedule I designation (HB6855). Effective Feb 2026.
DelawareLegal
No restrictions.
FloridaRestricted
Legal except Sarasota County ban. 7-OH products restricted.
GeorgiaRegulated
KCPA. Age raised to 21+ in Jan 2025.
Age: 21+
HawaiiPending
Currently legal. Ban legislation under consideration.
IdahoLegal
Legal. KCPA bill (SB 1282) stalled in committee.
IllinoisRegulated
KCPA in effect.
Age: 18+
IndianaBanned
Banned since 2014.
IowaPending
Currently legal. SF 2013 proposes Schedule I classification.
Age: 18+
KansasLegal
Minimal restrictions.
KentuckyRegulated
Legal with KCPA-style regulation.
LouisianaBanned
NEW BAN Aug 2025 (SB 154). Up to 5 years imprisonment.
MaineLegal
No statewide restrictions.
MarylandRegulated
KCPA passed and signed 2024.
MassachusettsPending
Currently legal. Competing KCPA & ban bills filed 2025.
MichiganPending
Currently legal. HB 5537 would prohibit kratom.
MinnesotaRegulated
Legal 18+. Pending KCPA review.
Age: 18+
MississippiRegulated
KCPA (HB1077) effective Jul 2025. Bans synthetic 7-OH.
Age: 21+
MissouriLegal
Legal. Regulations under review.
MontanaLegal
No specific regulation.
NebraskaLegal
No specific regulation.
NevadaRegulated
KCPA passed.
New HampshireLegal
Legal 18+. Some local variations.
Age: 18+
New JerseyLegal
No specific kratom regulation.
New MexicoLegal
No specific regulation.
New YorkRegulated
21+ sales restriction implemented 2025.
Age: 21+
North CarolinaLegal
Legal. 18+ age practice widely followed.
Age: 18+
North DakotaLegal
No specific regulation.
OhioRestricted
Emergency rule Dec 2025: bans most products except pure mitragynine.
OklahomaRegulated
KCPA regulation established.
OregonRegulated
21+ age req. Kratom must be disclosed as ingredient.
Age: 21+
PennsylvaniaLegal
No specific kratom regulation.
Rhode IslandLegal
Ban REVERSED Jul 2025. Regulated framework effective Apr 1, 2026.
South CarolinaRegulated
KCPA signed May 2025. Locked display cases required.
South DakotaLegal
Legal 21+. Ban attempt failed Jan 2026.
Age: 21+
TennesseeBanned
Complete statewide ban effective 07/01/2026
TexasLegal
Legal. Pending regulation bills.
UtahRegulated
KCPA passed. SB 45 pending would repeal KCPA.
VermontBanned
Complete statewide ban.
VirginiaRegulated
KCPA passed 2023.
WashingtonRestricted
Legal except Spokane city ban (Mar 2026). 95% tax proposed.
West VirginiaRegulated
KCPA passed 2023.
WisconsinBanned
Statewide prohibition.
WyomingLegal
No specific regulation.

By the Numbers: 2026 Snapshot

16
States with KCPA or similar regulation
19
States legal with no specific law
8
States with full bans
3
States with partial restrictions
4+
States with major pending bills

What’s Happening with 7-OH?

One of the biggest developments in 2025 was the wave of action around 7-hydroxymitragynine (7-OH), a concentrated kratom derivative. Here’s the key context:

✅ Federal Status Kratom itself remains unscheduled and legal at the federal level as of March 2026. The HHS scheduling recommendation specifically targets synthetic 7-OH — not natural kratom leaf or traditional kratom products.

At Phytoextractum, we have never sold or supported synthetic 7-OH products. We believe the distinction between natural kratom and synthetic derivatives is critically important, and we support sensible regulation that protects consumers while preserving access to natural, lab-tested kratom.

States that have independently restricted or banned 7-OH products include: Louisiana, Connecticut, Mississippi, Colorado, Florida, Ohio, Tennessee, and South Carolina — though in many of these states, natural kratom remains fully legal and accessible.

Why Advocacy Matters More Than Ever

If the timeline above makes one thing clear, it’s that nothing is settled. States are moving in both directions — some passing protections (Mississippi, South Carolina, Rhode Island) while others advance new bans (Connecticut, Tennessee, Michigan). The outcome often depends on whether informed voices show up to the conversation.

Here’s what you can do:

💬 Contact Your Reps
State legislators vote on kratom bills. A personal call or email from a constituent makes a real difference — especially when bills are in committee.
📜 Support the KCPA
The Kratom Consumer Protection Act creates a responsible framework: age restrictions, lab testing requirements, and labeling standards. It’s the opposite of an unregulated free-for-all.
🤝 Join the AKA
The American Kratom Association coordinates advocacy efforts nationwide. They track bills, mobilize supporters, and provide resources for testimony and public comment.

We’ll Keep This Updated

We plan to update this guide regularly as new legislation passes, existing bills advance, and the legal landscape continues to evolve. Bookmark this page and check back so you never miss an update.

Have a question about kratom legality in your specific area? Drop us a note at info@phytoextractum.com and we’ll do our best to point you in the right direction.

As always, thank you for being part of the Phyto family. Your support — and your advocacy — makes all the difference.

⚠️ Reminder This article is updated periodically but may not reflect the very latest changes in every jurisdiction. Always check your state and local laws before making purchasing decisions. This is not legal advice.

Filed Under: Kratom Tagged With: advocacy, american kratom association, kratom, legality, legislation, regulation

20 Years of Trust: Phytoextractum’s Journey

October 15, 2025 by Phyto

In 2005, Phytoextractum was born out of a passion for botanical discovery and a vision for a better future for kratom. At the time, few had even heard of kratom, and the idea of an online vendor dedicated to this remarkable plant was revolutionary. Fast-forward 20 years, and we are proud to stand as one of the longest-running, most trusted names in the kratom industry.

Our journey has been anything but simple. From the early days of explaining what kratom even was, to the turbulence of FDA and DEA scrutiny, to today’s more established—but still evolving—market, we have remained committed to our core values: integrity, quality, and community.

From Family Startup to Industry Leader

What began as a small family operation in Portland has since grown into a robust company with over 20 employees and a full-scale warehouse. Our team is made up of eclectic and passionate individuals who reflect the unique, vibrant culture of Portland itself. Each member brings something different to the table, but we are united by a shared mission: to provide the kratom community with products we ourselves would proudly use.

This growth wasn’t just about expanding operations—it was about creating something sustainable, trustworthy, and enduring in an industry that has faced more than its fair share of challenges.

Standing Strong Through Industry Challenges

The kratom world has seen its highs and lows. We’ve been there through every chapter:

  • 2005–2010: Introducing kratom to an online audience and building trust one customer at a time.
  • 2010–2015: Supporting advocacy efforts, including major donations to the American Kratom Association and botanical research initiatives.
  • 2015–2020: Weathering regulatory storms and standing firm in the face of attempted bans.
  • 2020–2025: Expanding responsibly while continuing to serve a passionate and growing community.

Every challenge strengthened our resolve. Every victory reaffirmed our belief in kratom’s potential to change lives.


Advocacy and Community Support

From the very beginning, advocacy has been central to who we are. We’ve proudly supported the American Kratom Association (AKA) and other botanical initiatives, helping ensure that kratom remains available and safe for responsible adults.

But advocacy goes beyond policy—it’s about people. It’s about making sure the voices of kratom consumers are heard, and that this community is represented fairly and honestly.

Gratitude for Our Customers

None of this would have been possible without you. Some of our customers have been with us since the very beginning—20 years of loyalty, trust, and shared passion for kratom. To you, and to every single person who has joined us along the way, we owe our deepest thanks.

Your support has allowed us to grow, to fight for kratom, and to continue offering the products you love. You are not just customers—you are part of the Phytoextractum family.


Looking Ahead

As we celebrate 20 years, we’re not just looking back—we’re looking forward. Our commitment to innovation, integrity, and community remains stronger than ever. The future of kratom is bright, and we are honored to continue leading the way with you by our side.

Here’s to the next 20 years.


Filed Under: Kratom Tagged With: advocacy, american kratom association, history, kratom

HHS Bans 7OH: A Win for Safe, Natural Kratom

July 29, 2025 by Phyto

The HHS emergency scheduling of 7-hydroxymitragynine (7OH) places this synthetic compound firmly in Schedule 1, effectively banning its sale, possession, and use in the U.S.

This move targets potent synthetic derivatives, not natural Kratom, but it’s a reminder of how vital it is to differentiate the two.

Why This Matters

We believe this is a necessary and positive step for the Kratom industry. At Phytoextractum, we have never sold or supported 7OH products, which run counter to our commitment to safe, natural botanicals.

Banning 7OH draws a line between natural Kratom and manipulated synthetics—a distinction critical to protecting responsible consumers and preventing unnecessary crackdowns on legitimate Kratom.

Our Natural Extract Promise

All Phytoextractum Kratom extracts and enhanced products are made exclusively from natural Kratom leaves or powders. Unlike synthetic derivatives such as 7OH, our extracts are crafted using traditional, plant-based methods that preserve the natural integrity of Kratom. Every product is rigorously tested in certified laboratories for purity, potency, and contaminants, ensuring you receive only the highest-quality, safest options available. Responsibly sourced from trusted growers and fully compliant with industry standards, our extracts offer a clean, consistent experience you can feel confident about.

👉 Shop 100% Natural Kratom Extracts →

The Road Ahead

While we support this scheduling, we remain vigilant. The fight to protect natural Kratom continues, and it’s essential to advocate for sensible regulation, not prohibition. This action by HHS also reinforces the need for consumers to choose reputable vendors who prioritize transparency and safety. At Phytoextractum, every product we sell is derived from 100% natural Kratom leaves and undergoes rigorous third-party lab testing to verify purity and potency. By avoiding synthetic derivatives like 7OH and focusing solely on natural Kratom, we’re proud to provide safe, high-quality products that align with responsible use and industry best practices.

Stay connected, stay informed, and join us in supporting science-based Kratom policies.

Buy Kratom online at Phytoextractum

Filed Under: Kratom Tagged With: advocacy, american kratom association, HHS, kratom, legislation

Last Chance: Louisiana Kratom Ban on 8/1

July 28, 2025 by Phyto

The countdown is on: Louisiana’s full Kratom ban takes effect on August 1, 2025. This means Louisiana residents have only a few days left to make their final Kratom purchases before the law prohibits sales and possession across the state.

If you’re in Louisiana, this is your last opportunity to prepare. Once the ban begins, we will no longer be able to ship Kratom to Louisiana addresses.

🌱 We’re Committed to Kratom Advocacy

This ban is a setback, but it’s also a reminder of why advocacy matters. Phytoextractum is dedicated to working alongside groups like the American Kratom Association (AKA) to fight misinformation and push for science-backed regulation that protects consumers rather than prohibiting access.

You can help by:

  • • Supporting the Kratom Consumer Protection Act in your state.
  • • Sharing your story with legislators to show the positive impact of Kratom.
  • • Joining organizations dedicated to preserving access to natural botanicals.


🚨 Stock Up Before It’s Too Late!

Don’t wait until it’s too late! Secure your favorite Kratom products today:

👉 Shop Kratom Powders →
👉 Shop Kratom Capsules
👉 Shop Kratom Extracts →
👉 Buy Kratom Shots →
👉 View All Kratom Products →

⚠️ Orders shipping to Louisiana must be completed before 8/1/2025.


Let’s Keep Fighting Together

Even as Louisiana moves forward with this ban, the Kratom community nationwide must stay strong. Advocacy efforts have successfully blocked prohibition in other states before, and with your help, they can succeed again.

Even as Louisiana’s ban takes hold, we must keep fighting for Kratom’s future. Advocacy has worked before—and together, we can make it work again.

Filed Under: Kratom Tagged With: advocacy, american kratom association, kratom, legislation, louisiana

Connecticut’s HB6855 Aims to Ban Kratom

June 5, 2025 by Phyto

A late-session amendment to Connecticut’s HB6855 — originally a hemp regulation bill — now threatens to classify kratom as a controlled substance, effectively banning access to the botanical across the state. The amended bill passed both chambers in just two days and now awaits Governor Ned Lamont’s signature.

The proposed language allows kratom to be scheduled “in the appropriate schedule,” a vague phrase that opens the door to extreme classification. Should kratom be added as a Schedule I substance, it would be treated the same as drugs like heroin or LSD, despite a lack of scientific evidence supporting such a designation. Even as a Schedule II or III drug, consumer access would be severely restricted.

Scientific Community and Advocates Push Back

Kratom is a natural plant with a centuries-long history of traditional use and growing support from researchers, healthcare practitioners, and millions of American consumers. Recent studies, including an FDA-led human tolerance study, demonstrate kratom’s relatively low risk profile. Neither the DEA nor the World Health Organization has recommended scheduling the plant, citing a lack of evidence of widespread harm.

Organizations like the Global Kratom Coalition and the American Kratom Association are urging the governor to veto the bill. In testimony, GKC’s Legislative Director, Walker Gallman, noted that kratom’s inclusion in HB6855 unjustly equates it with synthetic substances like tianeptine and phenibut, which carry significantly different risk profiles.

Our Role in Advocacy

At Phytoextractum, we’re deeply committed to the safe, responsible future of kratom. Through direct support of advocacy organizations, education campaigns, and legislative outreach, we are doing everything in our power to preserve consumer access and promote evidence-based regulation — not fear-driven prohibition. We stand in firm opposition to HB6855 and any legislation that ignores the science in favor of political expedience.

Take Action Now

If you live in Connecticut or care about kratom’s future, we encourage you to contact Governor Ned Lamont today and respectfully urge a veto of HB6855.

📞 Call: 860-566-4840 (Press 1)
📧 Email: Governor Lamont’s Contact Form

Let’s keep kratom accessible, safe, and grounded in science — not stigma.

Filed Under: Kratom Tagged With: advocacy, american kratom association, kratom, legislation

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 5
  • Go to Next Page »

Primary Sidebar

Latest Resources

  • That’s Not Kratom. Here’s What Phytoextractum Sells Instead.
  • Kratom Near Me? Why Online Beats Your Local Shop
  • Kratom Laws in 2026: Your State-by-State Guide
  • 20 Years of Trust: Phytoextractum’s Journey
  • HHS Bans 7OH: A Win for Safe, Natural Kratom

Resource Categories

  • CBD
  • Guide
  • Kava
  • Kratom
  • Mushrooms

Search Resources

QUICK LINKS

    • Home
    • Discount Coupons
    • Bitcoin
    • FAQ
    • Affiliates

 

INFORMATION

    • About Us
    • Sitemap
    • Lab Testing
    • COD
    • Customer Rewards

 

CUSTOMER SERVICE

  • Contact Us
  • Shipping & Returns
  • Privacy Policy
  • Terms & condition
  • My Account
Bitcoin logo

© 2023 Phytoextractum - Resources. All Rights Reserved.